Re: Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting.
Rosenwasser
Robert H
RH
D003422:Critical Care; D004333:Drug Administration Routes; D006352:Heart Ventricles; D006801:Humans; D019586:Intracranial Hypertension / Q000150:complications; D009325:Nausea / Q000209:etiology; D009599:Nitroprusside / Q000008:administration & dosage / Q000009:adverse effects*; D015203:Reproducibility of Results; D012107:Research Design; D013885:Thiosulfates / Q000008:administration & dosage / Q000009:adverse effects*; D020301:Vasospasm, Intracranial / Q000150:complications / Q000188:drug therapy*
D013885:Thiosulfates; D009599:Nitroprusside